Sensei Biotherapeutics to Present Topline Clinical Data from

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Boston , Massachusetts , Chicago , Illinois , American , Joyce Allaire , Shiraj Sen , Michael Biega , Sensei Biotherapeutics , Exchange Commission , Nasdaq , Linkedin , Sensei Biotherapeutics Inc , American Society Of Clinical Oncology , Present Topline Clinical Data , Dose Escalation Study , Clinical Oncology , Annual Meeting , Developmental Therapeutics , Tumor Microenvironment Activated , Immunoglobulin Domain Containing , Private Securities Litigation Reform Act , Annual Report , Periodic Reports ,